Saverna Therapeutics

Switzerland
Allschwil, Basel-Landschaft, Switzerland, 4123

Company profile

Saverna Therapeutics company profile

Saverna Therapeutics provides a drug discovery platform that combines fragment-based screening, nuclear magnetic resonance spectroscopy, and machine learning for the discovery of promising small molecule drugs selectively targeting specific microRNAs.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2017-11-01

Headquarters

Postal code
4123
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Last funding
Series Unknown / 2020-01-01
Last equity funding
Series Unknown
Investors
2
Lead investors
1

Founders and investors

Lead investors

Eurostars

Investors

EurostarsViva BioInnovator